This study investigates the use of an investigational medication in people with advanced solid tumors. The purpose of this study is to understand how the body processes the medication and to check for any side effects.
The study evaluates the safety and tolerability of the investigational medication. Researchers will also look into how the medication affects the tumors.
- Who can participate: Adults 18 years and older with advanced solid tumors may participate. Key eligibility includes adequate health status and availability of tumor tissue samples.
- Study details: Participants will receive the investigational medication through an IV infusion. They may receive up to 35 treatments if there are no severe side effects and the cancer does not progress. A placebo, an inactive substance that looks like the investigational medicine but does not contain any medicine, may be used for comparison.
How understandable was the trial content above?
Hard to understand
Easy to understand